This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CSII Cardiovascular Systems (CSII) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cardiovascular Systems Stock (NASDAQ:CSII) 30 days 90 days 365 days Advanced Chart Get Cardiovascular Systems alerts:Sign Up Key Stats Today's Range$20.00▼$20.0050-Day Range$19.87▼$20.0052-Week Range$12.26▼$20.57Volume4,300 shsAverage Volume765,906 shsMarket Capitalization$843.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. Read More Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address CSII Stock News HeadlinesResearch shows how trained immunity links to cardiovascular diseaseNovember 8, 2024 | msn.comLarge-scale genetic study identifies targets that could reduce cardiovascular risk by modulating blood metabolitesOctober 29, 2024 | msn.comCritical AI announcement set to ignite AI 2.0 Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet. That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions. | Timothy Sykes (Ad)Migraines linked to healthy vascular system despite cardiovascular risk factorsOctober 23, 2024 | msn.comCardiovascular scientists identify potential new treatment for failing heartsOctober 17, 2024 | msn.comRisk for Most Cardiovascular Events Reduced After COVID-19 VaccinationOctober 17, 2024 | msn.comStanding more may not reduce cardiovascular disease risk, could increase circulatory issuesOctober 17, 2024 | msn.comNew nanotherapy targets artery inflammation in cardiovascular diseaseOctober 11, 2024 | msn.comSee More Headlines CSII Stock Analysis - Frequently Asked Questions How were Cardiovascular Systems' earnings last quarter? Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The firm's revenue was up 3.9% compared to the same quarter last year. What other stocks do shareholders of Cardiovascular Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiovascular Systems investors own include Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA) and Home Depot (HD). Company Calendar Last Earnings2/08/2023Today8/08/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CSII CIK1180145 Webwww.csi360.com Phone(651) 259-1600Fax612-677-3355Employees780Year Founded1989Profitability EPS (Trailing Twelve Months)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$36.93 million Net Margins-15.79% Pretax Margin-15.73% Return on Equity-15.39% Return on Assets-11.93% Debt Debt-to-Equity Ratio0.08 Current Ratio6.04 Quick Ratio4.92 Sales & Book Value Annual Sales$239.84 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book3.27Miscellaneous Outstanding Shares42,198,000Free Float40,594,000Market Cap$843.96 million OptionableOptionable Beta0.74 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:CSII) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiovascular Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiovascular Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
